Alx Oncology Holdings (ALXO) Non Operating Interest Expenses (2022 - 2026)
Alx Oncology Holdings (ALXO) reported Non Operating Interest Expenses of $285,000 for Q2 2026, down 29.6% from $405,000 a year earlier and down 13.9% from the prior quarter.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alx Oncology Holdings' Non Operating Interest Expenses came in at $1.41 million, down 16.4% year-over-year; for FY2025, it was $1.6 million, down 7.3% from FY2024.
- Non Operating Interest Expenses has a four-year compound annual growth rate of 233.2% (FY2021 to FY2025).
- By year, Non Operating Interest Expenses came in at $1.73 million in FY2024 (+10.5%), $1.57 million in FY2023 (+557.6%), $238,000 in FY2022 and $13,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Interest Expenses since Q4 2022.
- Year over year, Non Operating Interest Expenses has now declined in each of the last six quarters, with an average decline of 7.6% over the last eight quarters.
- The high point for year-over-year Non Operating Interest Expenses in five years was Q4 2023 (growth of 79.7%); the low point was Q2 2026 (a decline of 29.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $331,000 (Q1 2026), $383,000 (Q4 2025) and $408,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Alx Oncology Holdings | 168.62 Mn | 168.62 Mn | - | 285,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 285,000.00 |
| Mar 31, 2026 | 331,000.00 |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | 408,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Mar 31, 2025 | 406,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 446,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 427,000.00 |
| Dec 31, 2023 | 415,000.00 |
| Sep 30, 2023 | 391,000.00 |
| Jun 30, 2023 | 372,000.00 |
| Mar 31, 2023 | 387,000.00 |
| Dec 31, 2022 | 231,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 3,000.00 |
API Access
Alx Oncology Holdings Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALXO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ALXO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALXO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();